Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol in Post-Traumatic Headache
NCT05595993Unknown
- Sponsor
- Dansk Hovedpinecenter
- Start
- Oct 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of cilostazol in post-traumatic headache (PTH), sponsored by Dansk Hovedpinecenter. Primary endpoint: Incidence of Migraine-Like Headache at 12 hours. Status: unknown.
02
Drugs
cilostazol
03
Conditions
post-traumatic headache (PTH)
Beyond the preview
Go deeper on NCT05595993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05595993.